Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Guardion Health Sciences Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
GHSI
Nasdaq
2833
http://guardionhealth.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Guardion Health Sciences Inc
Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon
- May 26th, 2022 1:00 pm
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022
- May 12th, 2022 12:13 pm
Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022
- May 3rd, 2022 7:45 pm
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
- Apr 27th, 2022 1:00 pm
Guardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify Store
- Apr 11th, 2022 1:17 pm
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021
- Apr 1st, 2022 1:03 pm
Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference
- Mar 11th, 2022 1:00 pm
Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering
- Feb 23rd, 2022 9:15 pm
Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering
- Feb 18th, 2022 2:00 pm
Guardion Health Sciences, Inc. Announces Proposed Public Offering
- Feb 17th, 2022 2:00 pm
Guardion Health Sciences Launches New Viactiv® Omega BOOST™ Passion Fruit Flavored Gel Bites
- Feb 14th, 2022 1:00 pm
Guardion Health Sciences Launches New Online Store for Viactiv
- Jan 24th, 2022 1:30 pm
Guardion Health Sciences to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
- Jan 6th, 2022 1:00 pm
Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual Property
- Dec 23rd, 2021 9:05 pm
Guardion Health Sciences Issues Letter to Shareholders
- Dec 16th, 2021 1:00 pm
Guardion Health Sciences Appoints Experienced Healthcare Executive Michaela Griggs to its Board of Directors
- Dec 9th, 2021 1:30 pm
Guardion Health Sciences to Present at the Benzinga Global Small Cap Conference
- Dec 3rd, 2021 1:00 pm
Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021
- Nov 10th, 2021 1:37 pm
Guardion Health Sciences Announces Corporate Milestones Designed to Strengthen Financial Results and Improve Customer and Investor Engagement
- Oct 14th, 2021 12:00 pm
Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting
- Oct 12th, 2021 2:30 pm
Scroll